A team of exceptional researchers are applying free-market principles in their efforts to tackle the devastating disease ...

Whether your stairs are straight, L-shaped or spiraled, these best vacuums for stairs tackle the dusty steps. Our editors and experts handpick every product we feature. We may earn a commission ...

Arexvy is an RSV vaccine currently authorised in the US and a further 35 countries. Credit: MargJohnsonVA/Shutterstock. GlaxoSmithKline (GSK) has received approval ...

Ferozan has over 20 years of experience writing and editing in the health and wellness sphere. She has worked as a ...

The GSK (LSE:GSK) share price has fallen off its perch. So it may be a good time to research and consider the stock opportunity. I think the global biopharma company has been dripping with promise ...

For instance, in July 2024, GlaxoSmithKline agreed to a $4.5 million settlement and to remove "non-drowsy" claims from its Robitussin products containing DXM. In the Robitussin case ...

The GSK share price has tumbled recently on a number of factors, but I think its fundamentals look strong, leaving the stock undervalued right now. When investing, your capital is at risk.

A judge in the U.K. last month sided with Pfizer over GSK in a respiratory syncytial virus vaccine patent lawsuit, positioning both companies to compete for that market and laying down a marker for ...

GSK’s (LSE: GSK) share price is down 28% from its 15 May 12-month traded high of £18.19. As a shareholder, this raises the question of whether I should sell, keep what I have, or buy more. In my ...